Natural history of 39 patients with Achondroplasia
Carregando...
Citações na Scopus
20
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
HOSPITAL CLINICAS, UNIV SAO PAULO
Citação
CLINICS, v.73, article ID UNSP e324, 5p, 2018
Resumo
OBJECTIVES: To characterize the natural history of 39 achondroplastic patients diagnosed by clinical, radiological and molecular assessments. METHODS: Observational and retrospective study of 39 patients who were attended at a public tertiary level hospital between 1995 and 2016. RESULTS: Diagnosis was made prenatally in 11 patients, at birth in 9 patients and within the first year of life in 13 patients. The most prevalent clinical findings were short stature, high forehead, trident hands, genu varum and macrocephaly. The most prevalent radiographic findings were rhizomelic shortening of the long bones and narrowing of the interpediculate distance of the caudal spine. There was motor developmental delay in 18 patients and speech delay in 16 patients. The most common clinical intercurrences were middle ear dysfunction, sleep apnea, limb pain and obesity from 2 to 9 years of age. One patient was large for the gestational age but did not develop obesity. One patient developed hydrocephalus at 10 years old. The current age of the patients varies from 15 months to 36 years. The molecular study performed by Sanger sequencing of the common heterozygous mutation 1138G >A in FGFR3 was positive in all patients. Four cases were inherited, and 35 were sporadic (paternal age from 19 to 66 years). CONCLUSIONS: The diagnoses were made early based on clinical and radiographic findings. All cases were confirmed molecularly. Despite presenting a benign course, it is necessary to establish a systematic protocol for the surveillance of these patients due to the common clinical intercurrences.
Palavras-chave
Achondroplasia, Natural History, Growth, FGFR3
Referências
- BELLUS GA, 1995, AM J HUM GENET, V56, P368
- Collins WO, 2007, ARCH OTOLARYNGOL, V133, P237, DOI 10.1001/archotol.133.3.237
- Fowler ES, 1997, J DEV BEHAV PEDIATR, V18, P143, DOI 10.1097/00004703-199706000-00001
- HECHT JT, 1987, AM J HUM GENET, V41, P454
- HORTON WA, 1978, J PEDIATR-US, V93, P435, DOI 10.1016/S0022-3476(78)81152-4
- Horton WA, 2009, TRENDS ENDOCRIN MET, V20, P341, DOI 10.1016/j.tem.2009.04.003
- Ireland PJ, 2012, J PAEDIATR CHILD H, V48, P443, DOI 10.1111/j.1440-1754.2011.02255.x
- Ireland PJ, 2010, J DEV BEHAV PEDIATR, V31, P41, DOI 10.1097/DBP.0b013e3181c72052
- LANGER LO, 1967, AMER J ROENTGENOL RA, V100, P12, DOI 10.2214/ajr.100.1.12
- Ornitz DM, 2005, CYTOKINE GROWTH F R, V16, P205, DOI 10.1016/j.cytogfr.2005.02.003
- PENROSE LS, 1955, LANCET, V2, P312
- Stoll C, 1982, Prog Clin Biol Res, V104, P419
- TODOROV AB, 1981, AM J MED GENET, V9, P19, DOI 10.1002/ajmg.1320090105
- Trotter TL, 2005, PEDIATRICS, V116, P771, DOI 10.1542/peds.2005-1440
- Unger S, 2017, CURR OSTEOPOROS REP, V15, P53, DOI 10.1007/s11914-017-0347-2
- Wilkin DJ, 1998, AM J HUM GENET, V63, P711, DOI 10.1086/302000
- Zhang R, 2006, P NATL ACAD SCI USA, V103, P365, DOI 10.1073/pnas.0507979103